Compare ARK Genomic Revolution ETF (ARKG) vs Futu Holdings Ltd (FUTU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Futu Holdings Ltd — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Futu Holdings Ltd trades at $95.45 (market cap $13.51B). The key difference: Futu Holdings Ltd pays a 2.7% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Futu Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | FUTU | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $199.04 |
52-Week Low | $23.09 | $89.76 |
Market Cap | — | $13.51B |
Enterprise Value | — | $13.36B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Futu Holdings trades at $96.33, down 0.71% on the day, with a neutral technical signal and key support at $95. The company reported strong 2025 revenue of $22.85 billion and net income of $11.34 billion, with high profitability margins. However, recent earnings misses and a securities class action lawsuit have introduced uncertainty.
The outlook is mixed: solid fundamentals and a 'Buy' analyst consensus support upside, but legal risks and earnings volatility pose significant headwinds. Investors should weigh the attractive valuation against potential regulatory and litigation overhangs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Futu Holdings Ltd
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →
